Dudediligence.

Fennec Pharmaceuticals Inc

FENCNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$7.0MSep ’24$7.9MDec ’24$8.8MMar ’25$9.7MJun ’25$12.5MSep ’25$13.8MDec ’25$15.1MMar ’26$17.9MJun ’26
Net income, by quarter
−$5.7MSep ’24−$2.0MDec ’24−$1.2MMar ’25−$3.2MJun ’25−$638,000Sep ’25−$4.8MDec ’25$201,000Mar ’26$2.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$1.5M$21.3M$47.5M$44.6M
Gross profitnone on file$1.4M$20.0Mnone on filenone on file
Operating income−$17.2M−$22.6M−$12.8M$2.6M−$6.3M
Net income−$17.3M−$23.7M−$16.0M−$436,000−$9.7M
Operating cash flow−$14.2M−$18.1M−$17.1M$27.0M−$12.5M
Cash$21.1M$23.8M$13.3M$26.6M$36.8M
Debtnone on file$24.9M$30.9M$19.3Mnone on file
Shares outstanding26.0M26.4M27.0M27.5M34.2M